Adiponectin promotes preadipocyte differentiation via the PPARγ pathway

Abstract

According to the results of a preliminary study, it was hypothesized that the effects of adiponectin (APN) on the improvement of atherosclerosis may be associated with adipocyte differentiation and peroxisome proliferator‑activated receptor γ (PPARγ). The present study simulated the inflammatory environment of epicardial adipose tissue by stimulating mature adipocytes with lipopolysaccharide (LPS); subsequently, the differentiation of 3T3‑L1 preadipocytes was observed. 3T3‑L1 preadipocytes were infected with an adenovirus containing the human adiponectin gene apM1 (Ad‑apM1) and were co‑cultured with mature adipocytes stimulated with LPS. Differentiation into mature adipocytes was initiated using differentiation medium. After 8 days, an MTT assay was used to examine cell viability and oil red O staining was used to observe preadipocyte differentiation. In addition, the mRNA expression levels of monocyte chemoattractant protein‑1 (MCP‑1), interleukin (IL)‑6, IL‑8 and tumor necrosis factor α (TNF‑α) were examined by quantitative polymerase chain reaction, and the protein expression levels of PPARγ, CCAAT/enhancer binding protein α (C/EBPα) and preadipocyte factor‑1 (Pref‑1) were measured by western blotting. The results indicated that APN overexpression significantly increased preadipocyte differentiation and cell viability, inhibited MCP‑1, IL‑6, IL‑8 and TNF‑α expression, upregulated PPARγ and C/EBPα expression, and downregulated Pref‑1 under LPS stimulation. In addition, inhibition of PPARγ activity by T0070907 markedly attenuated the effects of APN overexpression. Taken together, the present study demonstrated that the effects of APN on the promotion of preadipocyte differentiation under inflammatory conditions may involve the PPARγ signaling pathway, and at least partly depends on upregulation of PPARγ expression.

Molecular Mechanism of Stem Cell Differentiation into Adipocytes and Adipocyte Differentiation of Malignant Tumor

“…Adipocyte differentiation was promoted by KLF16 knockdown but was inhibited by KLF16 overexpression via inhibition of PPAR γ promoter activity [ 64 ]. In addition, KLF3 and KLF7 were also found to play a negative regulatory role in adipocyte differentiation [ 65 , 66 ].…”

Kaempferol Improves Lung Ischemia-Reperfusion Injury via Antiinflammation and Antioxidative Stress Regulated by SIRT1/HMGB1/NF-κB Axis

“…Western blotting was performed as previously (Yang et al, 2017). Briefly, a total of 30 mg protein from each tissue sample was separated and electrotransferred onto polyvinylidene difluoride membranes that was probed with primary antibodies (1:500) diluted in 5% nonfat milk and incubated at 4°C overnight.…”

Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment

“…A key mechanism by which epicardial mesenchymal cells evolve into nutriutive adipocytes is PPAR‐γ signalling . Dysmetabolism‐mediated inflammation impairs PPAR‐γ expression, but costimulation of PPAR‐γ and adiponectin reverses the dysfunctional state of epicardial fat .…”

“…A key mechanism by which epicardial mesenchymal cells evolve into nutriutive adipocytes is PPAR-signalling. 171,172 Dysmetabolism-mediated inflammation impairs PPARexpression, 173 but costimulation of PPAR-and adiponectin reverses the dysfunctional state of epicardial fat. 174,175 Presumably as a result of this action, pioglitazone attenuates atrial inflammation and fibrosis and alleviates the predilection for AF in experimental models of cardiac stress.…”